logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9657043 B1

PDFFull Text
Date of Patent:
May. 23, 2017

Filed:

Apr. 23, 2013

Amine compound and use thereof for medical purposes

Applicant:

Mitsubishi Tanabe Pharma Corporation, Osaka-shi, Osaka, JP;

Inventors:

Maiko Hamada, Osaka, JP;

Kaoru Tashiro, Osaka, JP;

Hiroshi Sakashita, Osaka, JP;

Masatoshi Kiuchi, Machida, JP;

Shuzo Takeda, Osaka, JP;

Kunitomo Adachi, Osaka, JP;

Assignee:

MITSUBISHI TANABE PHARMA CORPORATION, Osaka-shi, JP;

Attorney:

Birch, Stewart, Kolasch & Birch, LLP

Primary Examiner:

Barbara P Badio

Int. Cl.
CPC ...
A61K 31/67 (2006.01); A61K 31/665 (2006.01); A61K 31/382 (2006.01); A61K 31/352 (2006.01); C07C 50/18 (2006.01); C07C 217/48 (2006.01); C07D 311/82 (2006.01); C07D 335/12 (2006.01); C07F 9/6553 (2006.01); C07D 311/86 (2006.01); C07F 9/655 (2006.01); C07F 9/6558 (2006.01); C07D 335/16 (2006.01); C07D 409/12 (2006.01); C07C 225/18 (2006.01); C07F 7/22 (2006.01);
U.S. Cl.
CPC ...
C07F 9/655372 (2013.01); C07C 225/18 (2013.01); C07D 311/82 (2013.01); C07D 311/86 (2013.01); C07D 335/12 (2013.01); C07D 335/16 (2013.01); C07D 409/12 (2013.01); C07F 7/2212 (2013.01); C07F 9/65522 (2013.01); C07F 9/65586 (2013.01); C07C 2103/18 (2013.01);
Abstract

The present invention provides a compound represented by the following formula (I): wherein each symbol is as described in the DESCRIPTION, which has a superior peripheral blood lymphocyte decreasing action, and is useful for the treatment or prophylaxis of autoimmune diseases; prophylaxis or suppression of resistance or acute rejection or chronic rejection of transplantation of organ or tissue; treatment or prophylaxis of graft-versus-host (GvH) disease due to bone marrow transplantation; or treatment or prophylaxis of allergic diseases.

Find Patent Forward Citations

Loading…